You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exophthalmos

Showing 1 - 25 of 89
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Exophthalmos, Graves Ophthalmopathy, Orbital Tumor Trial in Zurich (Exophthalmos measurement)

Recruiting
  • Exophthalmos
  • +3 more
  • Exophthalmos measurement
  • Zurich, Switzerland
    Ophthalmology Department, University Hospital Zurich
Jan 10, 2021

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Beverly Hills, California
  • +22 more
Jan 30, 2023

Thyroid Eye Disease, TED Trial in Shanghai (IBI311)

Recruiting
  • Thyroid Eye Disease, TED
  • Shanghai, Shanghai, China
    Ninth People's Hospital Affiliated to Shanghai Jiao Tong Univers
Nov 9, 2023

Exophthalmos, Orbitopathy, Graves, Surgery Trial (Orbital decompression with ultrasonic bone removal)

Completed
  • Exophthalmos
  • +2 more
  • Orbital decompression with ultrasonic bone removal
  • (no location specified)
Jul 18, 2019

Graves Ophthalmopathy Trial in Pisa (Sirolimus)

Not yet recruiting
  • Graves Ophthalmopathy
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
Nov 2, 2022

Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)

Recruiting
  • Tocilizumab
  • Thyroid Associated Ophthalmopathy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Oct 11, 2023

Thyroid Eye Disease Trial in Miami (TOUR006 - 20 MG, Placebo, TOUR006 - 50 MG)

Recruiting
  • Thyroid Eye Disease
  • TOUR006 - 20 MG
  • +2 more
  • Miami, Florida
    Site - 0103
Oct 11, 2023

Thyroid Associated Ophthalmopathy, Surgical Procedure, Unspecified Trial in Manresa (3D printing model/guide., Standard surgery)

Recruiting
  • Thyroid Associated Ophthalmopathy
  • Surgical Procedure, Unspecified
  • 3D printing model/guide.
  • Standard surgery
  • Manresa, Barcelona, Spain
    Eduard Pedemonte Sarrias
Mar 8, 2022

Thyroid Eye Disease, Graves Orbitopathy Trial in Germany (Secukinumab, Placebo)

Recruiting
  • Thyroid Eye Disease
  • Graves Orbitopathy
  • Essen, Germany
  • +6 more
Jul 14, 2022

Sirolimus in Graves' Orbitopathy

Completed
  • Graves Ophthalmopathy
  • Pisa, PI, Italy
    Endocrinologia II
Apr 19, 2022

Thyroid Associated Ophthalmopathy Trial in Guangzhou (Doxycycline Hyclate)

Recruiting
  • Thyroid Associated Ophthalmopathy
  • Doxycycline Hyclate
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Nov 7, 2021

Thyroid Ophthalmopathy Trial in Shanghai (HBM9161 680 mg qw by q2w from week 13, Placebo, HBM9161 680 mg qw by q2w from week 7)

Recruiting
  • Thyroid Ophthalmopathy
  • HBM9161 680 mg qw by q2w from week 13
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital, Shanghai Jiaotong University S
Feb 22, 2022

Thyroid Associated Ophthalmopathies Trial (Sodium selenate, Sugar pill)

Withdrawn
  • Thyroid Associated Ophthalmopathies
  • Sodium selenate
  • Sugar pill
  • (no location specified)
Aug 12, 2021

Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)

Recruiting
  • Graves Ophthalmopathy
  • Hsinchu, Taiwan
  • +1 more
Dec 1, 2022

Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)

Completed
  • Thyroid Associated Orbitopathy
  • Cairo, Egypt
    Cairo University
Jul 15, 2022

Thyroid Associated Ophthalmopathy, Hypercholesterolemia Trial in Pisa (Atorvastatin, Methylprednisolone)

Completed
  • Thyroid Associated Ophthalmopathy
  • Hypercholesterolemia
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology I and II
Aug 12, 2021

Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)

Not yet recruiting
  • Thyroid-Associated Ophthalmopathy
  • (no location specified)
Mar 18, 2022

Patient Acceptance of Health Care Trial in Shanghai (Methimazole(MMI))

Recruiting
  • Patient Acceptance of Health Care
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiaotong University School of Medicine
Sep 4, 2021

Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)

Recruiting
  • Graves Ophthalmopathy
  • +8 more
  • Doxycycline hyclate
  • Placebo
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Nov 16, 2021

Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy Trial in Malmö (Simvastatin 40mg)

Recruiting
  • Graves Ophthalmopathy
  • +2 more
  • Simvastatin 40mg
  • Malmö, Sweden
    Dpt. of Endocrinology, SUS Malmö
Nov 17, 2021

Arteriovenous Fistula, Brachial Plexus Block, Clinical Efficacy Trial (Supraclavicular block, Axillary block)

Not yet recruiting
  • Arteriovenous Fistula
  • +2 more
  • Supraclavicular block
  • Axillary block
  • (no location specified)
Mar 29, 2023

Graves' Orbitopathy Trial in Pisa (Atorvastatin 20mg, Placebo)

Not yet recruiting
  • Graves' Orbitopathy
  • Atorvastatin 20mg
  • Placebo
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
Sep 8, 2021

Thyroid Associated Ophthalmopathy Trial (Orbital radiotherapy, Methylprednisolone)

Not yet recruiting
  • Thyroid Associated Ophthalmopathy
  • (no location specified)
Mar 24, 2020

Thyroid Associated Ophthalmopathies Trial in Petach Tikva (bimatoprost 0.03%)

Completed
  • Thyroid Associated Ophthalmopathies
  • bimatoprost 0.03%
  • Petach Tikva, Israel
    Ophthalmology clinics, Rabin Medical Center
Feb 15, 2018